These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 32912791)

  • 1. The role of insulin resistance in the relation of visceral, abdominal subcutaneous and total body fat to cardiovascular function.
    Paiman EHM; de Mutsert R; Widya RL; Rosendaal FR; Jukema JW; Lamb HJ
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2230-2241. PubMed ID: 32912791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Abdominal Subcutaneous and Visceral Fat with Insulin Resistance and Secretion Differ Between Men and Women: The Netherlands Epidemiology of Obesity Study.
    de Mutsert R; Gast K; Widya R; de Koning E; Jazet I; Lamb H; le Cessie S; de Roos A; Smit J; Rosendaal F; den Heijer M
    Metab Syndr Relat Disord; 2018 Feb; 16(1):54-63. PubMed ID: 29338526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of C-reactive protein, adiponectin and leptin in the association between abdominal adiposity and insulin resistance in middle-aged individuals.
    Noordam R; Boersma V; Verkouter I; le Cessie S; Christen T; Lamb HJ; Rosendaal FR; Willems van Dijk K; van Heemst D; de Mutsert R
    Nutr Metab Cardiovasc Dis; 2020 Jul; 30(8):1306-1314. PubMed ID: 32507340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual contributions of visceral fat and total body fat to subclinical atherosclerosis: The NEO study.
    Gast KB; den Heijer M; Smit JW; Widya RL; Lamb HJ; de Roos A; Jukema JW; Rosendaal FR; de Mutsert R;
    Atherosclerosis; 2015 Aug; 241(2):547-54. PubMed ID: 26100677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CETP concentration is not associated with measures of body fat: The NEO study.
    Blauw LL; de Mutsert R; Lamb HJ; de Roos A; Rosendaal FR; Jukema JW; Wang Y; van Dijk KW; Rensen PC
    Atherosclerosis; 2016 Mar; 246():267-73. PubMed ID: 26820801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of abdominal adiposity, hepatic shear stiffness with subclinical left-ventricular remodeling evaluated by magnetic resonance in adults free of overt cardiovascular diseases: a prospective study.
    Qu Y; Liu J; Li J; Shen S; Chen X; Tang H; Yuan Y; Xia C; Deng L; Chen G; Zheng T; Chen J; Nie L; Yuan F; Tong N; Peng L; Song B
    Cardiovasc Diabetol; 2023 Apr; 22(1):99. PubMed ID: 37120545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of inflammation in the association between overall and visceral adiposity and subclinical atherosclerosis.
    Christen T; Trompet S; Rensen PCN; Willems van Dijk K; Lamb HJ; Jukema JW; Rosendaal FR; le Cessie S; de Mutsert R
    Nutr Metab Cardiovasc Dis; 2019 Jul; 29(7):728-735. PubMed ID: 31138500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of regional fat distribution to left ventricular structure and function.
    Neeland IJ; Gupta S; Ayers CR; Turer AT; Rame JE; Das SR; Berry JD; Khera A; McGuire DK; Vega GL; Grundy SM; de Lemos JA; Drazner MH
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):800-7. PubMed ID: 23929898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of measures of body fat with serum alpha-tocopherol and its metabolites in middle-aged individuals.
    Meulmeester FL; Luo J; Martens LG; Ashrafi N; de Mutsert R; Mook-Kanamori DO; Lamb HJ; Rosendaal FR; Willems van Dijk K; Mills K; van Heemst D; Noordam R
    Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2407-2415. PubMed ID: 34158242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy.
    Klaver M; van Velzen D; de Blok C; Nota N; Wiepjes C; Defreyne J; Schreiner T; Fisher A; Twisk J; Seidell J; T'Sjoen G; den Heijer M; de Mutsert R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):e153-e164. PubMed ID: 34415999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between abdominal adiposity and subclinical measures of left-ventricular remodeling in diabetics, prediabetics and normal controls without history of cardiovascular disease as measured by magnetic resonance imaging: results from the KORA-FF4 Study.
    Schlett CL; Lorbeer R; Arndt C; Auweter S; Machann J; Hetterich H; Linkohr B; Rathmann W; Peters A; Bamberg F
    Cardiovasc Diabetol; 2018 Jun; 17(1):88. PubMed ID: 29895299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of different body fat deposits with serum 25-hydroxyvitamin D concentrations.
    Rafiq R; Walschot F; Lips P; Lamb HJ; de Roos A; Rosendaal FR; Heijer MD; de Jongh RT; de Mutsert R
    Clin Nutr; 2019 Dec; 38(6):2851-2857. PubMed ID: 30635144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome associates with left atrial dysfunction.
    Nyman K; Granér M; Pentikäinen MO; Lundbom J; Hakkarainen A; Sirén R; Nieminen MS; Taskinen MR; Lundbom N; Lauerma K
    Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):727-734. PubMed ID: 29764718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study.
    Preis SR; Massaro JM; Robins SJ; Hoffmann U; Vasan RS; Irlbeck T; Meigs JB; Sutherland P; D'Agostino RB; O'Donnell CJ; Fox CS
    Obesity (Silver Spring); 2010 Nov; 18(11):2191-8. PubMed ID: 20339361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential association of abdominal, liver, and epicardial adiposity with anthropometry, diabetes, and cardiac remodeling in Asians.
    Lee V; Han Y; Toh DF; Bryant JA; Boubertakh R; Le TT; Chin CWL
    Front Endocrinol (Lausanne); 2024; 15():1439691. PubMed ID: 39257902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Hepatic Triglyceride Content and Coagulation Factors: The Netherlands Epidemiology of Obesity Study.
    Morelli VM; de Mutsert R; de Roos A; Lamb HJ; van Hylckama Vlieg A; Bos MHA; Rosendaal FR; Lijfering WM; Cannegieter SC
    Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):3004-3014. PubMed ID: 33115270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship among central obesity, systemic inflammation, and left ventricular diastolic dysfunction as determined by structural equation modeling.
    Wu CK; Yang CY; Lin JW; Hsieh HJ; Chiu FC; Chen JJ; Lee JK; Huang SW; Li HY; Chiang FT; Chen JJ; Tsai CT
    Obesity (Silver Spring); 2012 Apr; 20(4):730-7. PubMed ID: 21394094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases.
    Faber DR; van der Graaf Y; Westerink J; Visseren FL
    Atherosclerosis; 2010 Sep; 212(1):274-80. PubMed ID: 20494358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of insulin resistance on subclinical left ventricular dysfunction in normal weight and overweight/obese japanese subjects in a general community.
    Hirose K; Nakanishi K; Daimon M; Sawada N; Yoshida Y; Iwama K; Yamamoto Y; Ishiwata J; Hirokawa M; Koyama K; Nakao T; Morita H; Di Tullio MR; Homma S; Komuro I
    Cardiovasc Diabetol; 2021 Jan; 20(1):22. PubMed ID: 33478525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of visceral and general obesity on vascular and left ventricular function and geometry: a cross-sectional magnetic resonance imaging study of the UK Biobank.
    van Hout MJP; Dekkers IA; Westenberg JJM; Schalij MJ; Scholte AJHA; Lamb HJ
    Eur Heart J Cardiovasc Imaging; 2020 Mar; 21(3):273-281. PubMed ID: 31722392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.